Main menu


You are here

Vaccinations

Pfizer to study using booster shot aimed at virus variant

Pfizer and its partner BioNTech said Thursday they are beginning a study to test whether a third shot of their COVID-19 vaccine will help protect against variants of the virus.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS of the difficulties in comparing vaccines

Yusuff Adebayo Adebisi knows that a vaccine that offers 70% protection against COVID-19 could be a valuable tool against the coronavirus pandemic in Nigeria — especially if that vaccine is cheap and doesn’t have to be stored at extremely cold temperatures. But what if another vaccine — one that is more expensive to buy and to store — was 95% effective?

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

High-End Medical Provider Reportedly Let Ineligible People Skip COVID-19 Vaccine Line

A national health care provider has administered COVID-19 vaccinations to people deemed ineligible for the scarce vaccine by local health departments, including people with connections to company leaders and customers of its concierge medical service, according to internal communications leaked to NPR.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

NIH to launch research into Covid long term effects, plus international roundup

Roundup:  NIH to study ‘long-haul’ virus symptoms

  WASHINGTON  (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.

Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.

Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.

Problem, Solution, SitRep, or ?: 

FDA says Johnson and Johnson vaccine provides protection against Covid, a step toward final decision

FDA says J&J 1-dose shot prevents COVID; final decision soon

WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.

That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S. On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot. Armed with that advice, FDA is expected to make a final decision within days. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Vaccinations
howdy folks
Page loaded in 0.710 seconds.